InO escape. Different mechanisms contributing to failure of InO therapy are depicted, particularly (1) antigen escape by alteration of CD22 epitope expression, preventing the antibody-drug conjugate from entering the CD22-positive B cell, and (2) resistance to the drug calicheamicin by compromised DNA damage or apoptotic responses. Mechanisms in bold were observed in the study by Zhao et al.